Published in BJU Int on April 01, 1999
Impaired anal sphincter function in professional cyclists. Wien Klin Wochenschr (2007) 0.77
Pelvic floor symptoms in female cyclists and possible remedies: a narrative review. Int Urogynecol J (2015) 0.75
Sport and male sexuality. J Endocrinol Invest (2017) 0.75
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res (2000) 2.64
Retinal side-effects of sildenafil. Lancet (1999) 2.40
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
EAU guidelines on prostate cancer. Eur Urol (2005) 1.88
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Sacral colpopexy with concurrent Burch colposuspension in patients with vaginal vault prolapse. Urol Int (2006) 1.60
Measurement of vaginal and minor labial oxygen tension for the evaluation of female sexual function. J Urol (2001) 1.59
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol (2003) 1.53
The prevalence of Peyronie's disease: results of a large survey. BJU Int (2001) 1.51
The integration of medical images with the electronic patient record and their web-based distribution. Acad Radiol (2004) 1.51
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Focal therapy in prostate cancer-report from a consensus panel. J Endourol (2010) 1.43
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.43
[Second-line thalidomide/IL-2 therapy in metastatic kidney cancer--results of a pilot study]. Aktuelle Urol (2006) 1.42
The Mainz pouch (mixed augmentation ileum 'n zecum) for bladder augmentation and continent urinary diversion. 1985. Eur Urol (2006) 1.39
Standardization of teleradiology using Dicom e-mail: recommendations of the German Radiology Society. Eur Radiol (2005) 1.23
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. Eur J Cancer (2011) 1.22
Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer (1998) 1.21
Giant calculus of the posterior urethra following recurrent penile urethral stricture. Urol Int (2002) 1.16
Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease. Cancer (1997) 1.05
Modulation of human platelet aggregation by the phosphodiesterase type 5 inhibitor sildenafil. J Cardiovasc Pharmacol (2001) 1.00
Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide. Prostate (1997) 0.99
Epidemiology of Peyronie's disease. Int J Impot Res (2002) 0.97
Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology (2011) 0.96
Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial. World J Urol (2005) 0.95
Local recurrence of an oncocytic adrenocortical carcinoma with ovary metastasis. J Urol (2001) 0.93
31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed (2002) 0.93
Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study. J Urol (1988) 0.93
Glial cell line-derived neurotrophic factor is constitutively produced by human testicular peritubular cells and may contribute to the spermatogonial stem cell niche in man. Hum Reprod (2010) 0.92
The Mainz pouch (mixed augmentation ileum and cecum) for bladder augmentation and continent diversion. J Urol (1986) 0.92
How to deal with security issues in teleradiology. Comput Methods Programs Biomed (1997) 0.92
Teleradiology applications with DICOM-e-mail. Eur Radiol (2006) 0.91
Generalized subcutaneous emphysema caused by injection of air into the penis for autoerotic purposes. Case Rep Nephrol Urol (2013) 0.91
[European Association of Urology guidelines on urinary and male genital tract infections]. Urologe A (2003) 0.89
Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis. Int J Cancer (2001) 0.89
Impotence and genital numbness in cyclists. Int J Sports Med (2001) 0.88
Radical cystectomy--often too late? Eur Urol (1987) 0.88
Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. J Urol (2001) 0.88
[Cytological aspects of the clinically healthy gingiva (author's transl)]. Zahn Mund Kieferheilkd Zentralbl (1980) 0.88
Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial. J Urol (2003) 0.86
Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology (1999) 0.86
[Isolated epididymal torsion in dissociation of testis-epididymis]. Urologe A (2002) 0.86
[Guidelines for German urologists on diagnosis of benign prostate syndrome]. Urologe A (2003) 0.85
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. Actas Urol Esp (2011) 0.85
Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia. Int Urol Nephrol (1999) 0.85
15-Deoxy-delta 12-14-prostaglandin-J2 induces hypertrophy and loss of contractility in human testicular peritubular cells: implications for human male fertility. Endocrinology (2010) 0.85
The Mainz pouch (mixed augmentation ileum 'n zecum) for bladder augmentation and continent urinary diversion. Eur Urol (1985) 0.85
Soluble guanylate cyclase and cGMP-dependent protein kinase I expression in the human corpus cavernosum. Int J Impot Res (2000) 0.84
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. Folia Biol (Praha) (2003) 0.84
Extending a teleradiology system by tools for 3D-visualization and volumetric analysis through a plug-in mechanism. Stud Health Technol Inform (1998) 0.84
[Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors]. Urologe A (2012) 0.84
Influence of cis-platinum on healing of enterostomies in the rat. Eur Urol (1983) 0.84
[The determination of patient satisfaction as a part of quality management in the hospital]. Dtsch Med Wochenschr (1996) 0.83
[Erectile dysfunction. Are interdisciplinary diagnosis and therapy necessary?]. Dtsch Med Wochenschr (2004) 0.83
Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results. Eur Urol (1998) 0.83
Evidence for the involvement of endothelial nitric oxide synthase from smooth muscle cells in the erectile function of the human corpus cavernosum. Urol Res (1998) 0.83
Erectile dysfunction in cyclists. Is there any difference in penile blood flow during cycling in an upright versus a reclining position? Eur Urol (2001) 0.83
[Guidelines of German urologists on therapy of benign prostate syndrome]. Urologe A (2003) 0.83
Impact of shock wave pattern and cavitation bubble size on tissue damage during ureteroscopic electrohydraulic lithotripsy. J Urol (1995) 0.83
Microsurgical epididymal sperm aspiration: aspirate analysis and straws available after cryopreservation in patients with non-reconstructable obstructive azoospermia. MESA/TESE Group Giessen. Hum Reprod (2000) 0.82
Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study. Andrologia (2009) 0.82
Inguinal fibrolipoma of the spermatic cord: discrepancies between clinical and histopathological findings. Urol Int (2003) 0.82
Minimally invasive treatment for localized prostate cancer. Minerva Urol Nefrol (2012) 0.81
Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA). Review of the literature and six years of clinical experience. Urol Int (2004) 0.81
MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum. Int J Impot Res (2002) 0.81
'Viagra effect' - influence of mass media on patient behavior. Urol Int (2001) 0.81
[Clodronate in the palliative therapy of bone-metastasized prostatic carcinoma]. Urologe A (1992) 0.81
Virtual surgery in a (tele-)radiology framework. IEEE Trans Inf Technol Biomed (1999) 0.81
Risk adjustment for evaluating the outcome of urological operative procedures. J Urol (2001) 0.80
Sildenafil (Viagra): is there an influence on psychological performance? Int Urol Nephrol (2001) 0.80
Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int (1999) 0.80
Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer. Eur Urol (2000) 0.80
Bladder carcinogenesis in portacaval shunt rats. Urol Int (1987) 0.80
Superselective embolization with coils in high-flow priapism. Cardiovasc Intervent Radiol (2002) 0.80
Pyruvate kinase type tumor M2 in urological malignancies. Urol Int (2003) 0.80
[The familial undescended testis]. Klin Padiatr (2003) 0.79
Experimental studies and first clinical experience with a new Lithoclast and ultrasound combination for lithotripsy. Eur Urol (2002) 0.79
Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers. World J Urol (2008) 0.79